Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-31

Clinical Trial Update: Effects of a NeuroAD System, for the Treatment of Alzheimer Disease [NA]

View source ↗

Summary

The clinical trial evaluating the NeuroAD System for Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neuronix Ltd | Conditions: Alzheimer's Disease | NA | Status: TERMINATED